Robert J. Altenbach
Neuroscience Research
Global Pharmaceutical Research and Development
Abbott Laboratories
100 Abbott Park Road
United States
Name/email consistency: high
- Diaryldiamines with dual inhibition of the histamine H(3) receptor and the norepinephrine transporter and the efficacy of 4-(3-(methylamino)-1-phenylpropyl)-6-(2-(pyrrolidin-1-yl)ethoxy)naphthalen-1-ol in pain. Altenbach, R.J., Black, L.A., Strakhova, M.I., Manelli, A.M., Carr, T.L., Marsh, K.C., Wetter, J.M., Wensink, E.J., Hsieh, G.C., Honore, P., Garrison, T.R., Brioni, J.D., Cowart, M.D. J. Med. Chem. (2010)
- Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands. Altenbach, R.J., Adair, R.M., Bettencourt, B.M., Black, L.A., Fix-Stenzel, S.R., Gopalakrishnan, S.M., Hsieh, G.C., Liu, H., Marsh, K.C., McPherson, M.J., Milicic, I., Miller, T.R., Vortherms, T.A., Warrior, U., Wetter, J.M., Wishart, N., Witte, D.G., Honore, P., Esbenshade, T.A., Hancock, A.A., Brioni, J.D., Cowart, M.D. J. Med. Chem. (2008)
- Synthesis, potency, and in vivo profiles of quinoline containing histamine H3 receptor inverse agonists. Altenbach, R.J., Liu, H., Banfor, P.N., Browman, K.E., Fox, G.B., Fryer, R.M., Komater, V.A., Krueger, K.M., Marsh, K., Miller, T.R., Pan, J.B., Pan, L., Sun, M., Thiffault, C., Wetter, J., Zhao, C., Zhou, D., Esbenshade, T.A., Hancock, A.A., Cowart, M.D. J. Med. Chem. (2007)
- Effects of substitution on 9-(3-bromo-4-fluorophenyl)-5,9-dihydro-3H,4H-2,6-dioxa-4- azacyclopenta[b]naphthalene-1,8-dione, a dihydropyridine ATP-sensitive potassium channel opener. Altenbach, R.J., Brune, M.E., Buckner, S.A., Coghlan, M.J., Daza, A.V., Fabiyi, A., Gopalakrishnan, M., Henry, R.F., Khilevich, A., Kort, M.E., Milicic, I., Scott, V.E., Smith, J.C., Whiteaker, K.L., Carroll, W.A. J. Med. Chem. (2006)
- Synthesis and structure-activity studies on N-[5-(1H-imidazol-4-yl)-5,6,7,8-tetrahydro-1-naphthalenyl]methanesulfonamide, an imidazole-containing alpha(1A)-adrenoceptor agonist. Altenbach, R.J., Khilevich, A., Kolasa, T., Rohde, J.J., Bhatia, P.A., Patel, M.V., Searle, X.B., Yang, F., Bunnelle, W.H., Tietje, K., Bayburt, E.K., Carroll, W.A., Meyer, M.D., Henry, R., Buckner, S.A., Kuk, J., Daza, A.V., Milicic, I.V., Cain, J.C., Kang, C.H., Ireland, L.M., Carr, T.L., Miller, T.R., Hancock, A.A., Nakane, M., Esbenshade, T.A., Brune, M.E., O'Neill, A.B., Gauvin, D.M., Katwala, S.P., Holladay, M.W., Brioni, J.D., Sullivan, J.P. J. Med. Chem. (2004)
- N-[3-(1H-imidazol-4-ylmethyl)phenyl]ethanesulfonamide (ABT-866, 1),(1) a novel alpha(1)-adrenoceptor ligand with an enhanced in vitro and in vivo profile relative to phenylpropanolamine and midodrine. Altenbach, R.J., Khilevich, A., Meyer, M.D., Buckner, S.A., Milicic, I., Daza, A.V., Brune, M.E., O'Neill, A.B., Gauvin, D.M., Cain, J.C., Nakane, M., Holladay, M.W., Williams, M., Brioni, J.D., Sullivan, J.P. J. Med. Chem. (2002)
